Israel: First Subject Enrolled

On February 12, 2013, the first subject was enrolled in our new Israeli study of MDMA-assisted psychotherapy for PTSD. This study will enroll 10 subjects with chronic, treatment-resistant PTSD, some of whom will be referred by the Israeli Defence Forces. This study is taking place at Beer Ya’akov Mental Hospital, and is led by Principal Investigator Moshe Kotler, M.D.

Clinical Investigator Keren Tzarfaty, Ph.D.(c) will give an update on our Israeli study on Saturday, April 20 at Psychedelic Science 2013.